» Articles » PMID: 21190998

IL-29 and IFNα Differ in Their Ability to Modulate IL-12 Production by TLR-activated Human Macrophages and Exhibit Differential Regulation of the IFNγ Receptor Expression

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2010 Dec 31
PMID 21190998
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

The interferon-λ (IFNλ) family of cytokines, consisting of interleukin-28A (IFNλ2), IL-28B (IFNλ3), and IL-29 (IFNλ1), have been extensively studied for their antiviral activities. However, little is known about the effect of IFNλ on antigen-presenting cells. In the present study, we show for the first time that IL-29 can increase Toll-like receptor (TLR)-induced IL-12p40 production by human monocyte-derived macrophages. In contrast, IL-29 did not affect monocytes or monocyte-derived dendritic cells (DCs) because of restricted IL-28 receptor α chain expression by macrophages. Furthermore, IL-29-treated macrophages were more responsive to IFNγ, because IL-29 enhanced IFNγ-induced IL-12p40 and tumor necrosis factor (TNF) production by macrophages on R848 stimulation. However, IFNα suppressed IFNγ-induced IL-12p40 and tumor necrosis factor TNF production by human macrophages. The differential effects of IL-29 and IFNα on the responsiveness of macrophages to IFNγ could not be explained by an effect on TLR7 or TLR8 mRNA expression or by altered IL-10 signaling. However, we demonstrated that IL-29 up-regulated, whereas IFNα down-regulated, the surface expression of the IFNγ receptor 1 chain on macrophages, thereby resulting in differential responsiveness of TLR-challenged macrophages to IFNγ. Our findings on the differences between IFNα and IL-29 in modulating TLR-induced cytokine production by macrophages may contribute to understanding the role of IFNs in regulating immunity to pathogens.

Citing Articles

Cell-intrinsic regulation of phagocyte function by interferon lambda during pulmonary viral, bacterial super-infection.

Antos D, Parks O, Duray A, Abraham N, Michel J, Kupul S PLoS Pathog. 2024; 20(8):e1012498.

PMID: 39178311 PMC: 11376568. DOI: 10.1371/journal.ppat.1012498.


Macrophages treated with interferons induce different responses in lymphocytes via extracellular vesicles.

Giannessi F, Percario Z, Lombardi V, Sabatini A, Sacchi A, Lisi V iScience. 2024; 27(6):109960.

PMID: 38832015 PMC: 11144789. DOI: 10.1016/j.isci.2024.109960.


Interferon Family Cytokines in Obesity and Insulin Sensitivity.

Huang L, Chiu C, Hsing C, Hsu Y Cells. 2022; 11(24).

PMID: 36552805 PMC: 9776768. DOI: 10.3390/cells11244041.


Membrane-Tethered Mucin 1 Is Stimulated by Interferon and Virus Infection in Multiple Cell Types and Inhibits Influenza A Virus Infection in Human Airway Epithelium.

Iverson E, Griswold K, Song D, Gagliardi T, Hamidzadeh K, Kesimer M mBio. 2022; 13(4):e0105522.

PMID: 35699372 PMC: 9426523. DOI: 10.1128/mbio.01055-22.


Recombinant Newcastle disease virus expressing human IFN-λ1 (rL-hIFN-λ1) inhibits lung cancer migration through repolarizating macrophage from M2 to M1 phenotype.

Yan Y, Zhang R, Zhang Y, Zhang X, Zhang A, Bu X Transl Cancer Res. 2022; 9(5):3392-3405.

PMID: 35117705 PMC: 8798182. DOI: 10.21037/tcr-19-2320.